P

Inventor

TANIS STEVEN P

US28 patents
⚠️ This page may combine multiple inventors who share the name “TANIS STEVEN P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARCTURUS THERAPEUTICS INC

10 patents
US10526284B2Jan 7, 2020

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC16 citations94
US10487105B2Nov 26, 2019

Trinucleotide MRNA cap analogs

ARCTURUS THERAPEUTICS INC19 citations94
US10383952B2Aug 20, 2019

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC13 citations92
US10980895B2Apr 20, 2021

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC8 citations84
US10961188B2Mar 30, 2021

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC7 citations84
US10233148B2Mar 19, 2019

Aromatic ionizable cationic lipid

ARCTURUS THERAPEUTICS INC6 citations84
US10227302B2Mar 12, 2019

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC12 citations84
US9834510B2Dec 5, 2017

Aromatic ionizable cationic lipid

ARCTURUS THERAPEUTICS INC4 citations73
US12527881B2Jan 20, 2026

Ionizable cationic lipid for RNA delivery

ARCTURUS THERAPEUTICS INC0 citations62
US9962449B2May 8, 2018

MultiLigand agent for drug delivery

ARCTURUS THERAPEUTICS INC0 citations52

UPJOHN CO

3 patents
US5245046ASep 14, 1993

α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents

UPJOHN CO23 citations92
US6686356B2Feb 3, 2004

Pyridoquinoxaline antivirals

UPJOHN CO14 citations84
US6589504B1Jul 8, 2003

Compounds and methods for diagnosing and treating amyloid-related conditions

UPJOHN CO10 citations64

PFIZER

3 patents
US6852731B2Feb 8, 2005

Antiviral compounds

PFIZER15 citations81
US6861438B2Mar 1, 2005

Antiviral agents

PFIZER0 citations39
US6878705B2Apr 12, 2005

4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents

PFIZER0 citations36

METABOLIC SOLUTIONS DEV CO LLC

3 patents
US9562012B2Feb 7, 2017

PPAR-sparing compounds for the treatment of metabolic diseases

METABOLIC SOLUTIONS DEV CO LLC6 citations70
US9126959B2Sep 8, 2015

PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

METABOLIC SOLUTIONS DEV CO LLC2 citations60
US8946435B2Feb 3, 2015

Synthesis for thiazolidinedione compounds

METABOLIC SOLUTIONS DEV CO LLC0 citations49

(unassigned)

2 patents
US5994577ANov 30, 1999

Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus

21 citations91
US6329545B1Dec 11, 2001

Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus

14 citations72

TANIS STEVEN P

2 patents
US8933240B2Jan 13, 2015

Synthesis for thiazolidinedione compounds

TANIS STEVEN P0 citations45
US8895748B2Nov 25, 2014

Synthesis for thiazolidinedione compounds

TANIS STEVEN P0 citations45

AGOURON PHARMA

1 patent
US7045646B2May 16, 2006

Process to produce enantiomerically enriched alcohols and amines

AGOURON PHARMA21 citations91

PHARMACIA IND

1 patent
US6166080ADec 26, 2000

Aminoquanidine carboxylates for the treatment of obesity

PHARMACIA IND6 citations71

C/O ARCTURUS THERAPEUTICS INC

1 patent
US10968248B2Apr 6, 2021

Trinucleotide mRNA cap analogs

C/O ARCTURUS THERAPEUTICS INC2 citations67

COLCA GERARD R

1 patent
US8912335B2Dec 16, 2014

PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

COLCA GERARD R2 citations61

ZELLER JAMES R

1 patent
US8937182B2Jan 20, 2015

Synthesis for thiazolidinedione compounds

ZELLER JAMES R3 citations56